during SEC proxy season, this institutional investor held about 5.9 per cent of all of Merck's then outstanding shares.
At year end this past year, the house held only about 4.7 per cent of Merck's then outstanding shares.
Here is a link to the latest SEC Schedule 13G amendment, filed by the Capital Group funds' affiliates.
Now you know -- and onward, back in the saddle, on a chilly flurry-speckled evening. . . . smile.